PTHS Stock Analysis: Buy, Sell, or Hold?
PTHS - Pelthos Therapeutics Inc.
$26.75
-0.84 (-3.04%)
▼
5d:
-0.41%
30d:
-7.85%
90d:
+7.99%
BUY
HIGH Confidence
Analysis Updated: Jul 27, 2026 12:00 AM ET
Earnings: Aug 12, 2026
14d
Get Alerted When PTHS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: PTHS shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: PTHS shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: PTHS is currently trading at $26.75, which is considered fair relative to its 30-day fair value range of $25.87 to $28.58.
Technical Outlook: Technically, PTHS is in a strong uptrend. Immediate support is located at $24.93, while resistance sits at $28.98. Short-term momentum is weak, with the stock down 3.0% recently.
Market Sentiment: PTHS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $57.71 (+109.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PTHS is in a strong uptrend. Immediate support is located at $24.93, while resistance sits at $28.98. Short-term momentum is weak, with the stock down 3.0% recently.
Market Sentiment: PTHS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $57.71 (+109.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$25.87 -
$28.58
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
81.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.0%)
- BULLISH: Trading 109.2% below Wall St target ($57.71)
Trading Range Analysis
30-Day Trading Range
$25.87 -
$28.58
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$24.93
Resistance Level
$28.98
Current Trend
Strong Uptrend
Technical data as of
Jul 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-12.98
Wall Street Target
$57.71
(+109.2%)
Profit Margin
-186.2%
Share & Embed Analysis
Last updated: July 28, 2026 12:14 PM ET
Data refreshes hourly during market hours. Next update: 1:14 PM
Data refreshes hourly during market hours. Next update: 1:14 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PTHS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Ezra M Friedberg
SELL
558 shares
2026-04-02
Peter Greenleaf
SELL
797 shares
2026-04-02
Richard Malamut
SELL
590 shares
2026-04-02
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$54 | 50 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$127 | 53 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$105 | 54 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 51 HOLD |
|
ARVN
Arvinas Inc |
BUY
21 analysts |
$15 | 56 HOLD |
